The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy.
<h4>Objectives</h4>The aim was to analyse the tumor expression of Notch1, Hes1, Ascl1, and DLL3 in Small-Cell Lung Cancer (SCLC) and each such biomarker's potential association with clinical characteristics and prognosis after platinum-doublet chemotherapy (PDCT).<h4>Material...
Main Authors: | Salomon Tendler, Lena Kanter, Rolf Lewensohn, Cristian Ortiz-Villalón, Kristina Viktorsson, Luigi De Petris |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0240973 |
Similar Items
-
Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo.
by: Kristina Preuße, et al.
Published: (2015-06-01) -
Promoters of ASCL1‐ and NEUROD1‐dependent genes are specific targets of lurbinectedin in SCLC cells
by: Federico Costanzo, et al.
Published: (2022-04-01) -
The ectodomains determine ligand function in vivo and selectivity of DLL1 and DLL4 toward NOTCH1 and NOTCH2 in vitro
by: Lena Tveriakhina, et al.
Published: (2018-10-01) -
Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
by: Geffers, I, et al.
Published: (2007) -
Dll1 Can Function as a Ligand of Notch1 and Notch2 in the Thymic Epithelium
by: Ken-ichi Hirano, et al.
Published: (2022-03-01)